Rua Life Sciences PLC (RUA) - Total Assets
Based on the latest financial reports, Rua Life Sciences PLC (RUA) holds total assets worth GBX9.12 Million GBX (≈ $1.11K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Rua Life Sciences PLC (RUA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Rua Life Sciences PLC - Total Assets Trend (1994–2025)
This chart illustrates how Rua Life Sciences PLC's total assets have evolved over time, based on quarterly financial data. See Rua Life Sciences PLC (RUA) net assets for net asset value and shareholders' equity analysis.
Rua Life Sciences PLC - Asset Composition Analysis
Current Asset Composition (September 2025)
Rua Life Sciences PLC's total assets of GBX9.12 Million consist of 59.2% current assets and 40.8% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 35.7% |
| Accounts Receivable | GBX1.25 Million | 13.7% |
| Inventory | GBX894.00K | 9.8% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX348.00K | 3.8% |
| Goodwill | GBX301.00K | 3.3% |
Asset Composition Trend (1994–2025)
This chart illustrates how Rua Life Sciences PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Rua Life Sciences PLC market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rua Life Sciences PLC's current assets represent 59.2% of total assets in 2025, an increase from 49.2% in 1994.
- Cash Position: Cash and equivalents constituted 35.7% of total assets in 2025, up from 0.1% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 19.0% in 1994.
- Asset Diversification: The largest asset category is accounts receivable at 13.7% of total assets.
Rua Life Sciences PLC Competitors by Total Assets
Key competitors of Rua Life Sciences PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.24 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Rua Life Sciences PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.64 | 6.47 | 1.67 |
| Quick Ratio | 3.87 | 5.25 | 1.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX4.23 Million | GBX5.00 Million | GBX561.00K |
Rua Life Sciences PLC - Advanced Valuation Insights
This section examines the relationship between Rua Life Sciences PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.74 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -1.5% |
| Total Assets | GBX9.12 Million |
| Market Capitalization | $181.22K USD |
Valuation Analysis
Below Book Valuation: The market values Rua Life Sciences PLC's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Rua Life Sciences PLC's assets decreased by 1.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Rua Life Sciences PLC (1994–2025)
The table below shows the annual total assets of Rua Life Sciences PLC from 1994 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | GBX9.12 Million ≈ $1.11K |
-1.49% |
| 2025-03-31 | GBX9.26 Million ≈ $1.13K |
+13.29% |
| 2024-03-31 | GBX8.17 Million ≈ $993.93 |
+44.25% |
| 2023-03-31 | GBX5.66 Million ≈ $689.02 |
-25.74% |
| 2022-03-31 | GBX7.63 Million ≈ $927.86 |
-24.90% |
| 2021-03-31 | GBX10.15 Million ≈ $1.24K |
+307.18% |
| 2020-03-31 | GBX2.49 Million ≈ $303.45 |
-19.52% |
| 2019-03-31 | GBX3.10 Million ≈ $377.06 |
+186.15% |
| 2018-03-31 | GBX1.08 Million ≈ $131.77 |
-4.44% |
| 2017-03-31 | GBX1.13 Million ≈ $137.89 |
-15.16% |
| 2016-03-31 | GBX1.34 Million ≈ $162.53 |
-24.91% |
| 2015-03-31 | GBX1.78 Million ≈ $216.46 |
-8.76% |
| 2014-03-31 | GBX1.95 Million ≈ $237.24 |
-36.30% |
| 2013-03-31 | GBX3.06 Million ≈ $372.45 |
-14.16% |
| 2012-03-31 | GBX3.57 Million ≈ $433.87 |
-5.71% |
| 2011-03-31 | GBX3.78 Million ≈ $460.16 |
-37.34% |
| 2010-03-31 | GBX6.04 Million ≈ $734.41 |
-10.22% |
| 2009-03-31 | GBX6.72 Million ≈ $817.99 |
-14.27% |
| 2008-03-31 | GBX7.84 Million ≈ $954.14 |
+113.27% |
| 2007-03-31 | GBX3.68 Million ≈ $447.38 |
-36.16% |
| 2006-03-31 | GBX5.76 Million ≈ $700.83 |
-4.02% |
| 2005-03-31 | GBX6.00 Million ≈ $730.15 |
-25.03% |
| 2004-03-31 | GBX8.01 Million ≈ $973.98 |
-13.37% |
| 2003-03-31 | GBX9.24 Million ≈ $1.12K |
-81.08% |
| 2002-03-31 | GBX48.84 Million ≈ $5.94K |
+26.92% |
| 2001-03-31 | GBX38.48 Million ≈ $4.68K |
-13.27% |
| 2000-03-31 | GBX44.37 Million ≈ $5.40K |
+717.20% |
| 1999-03-31 | GBX5.43 Million ≈ $660.55 |
+39.10% |
| 1998-03-31 | GBX3.90 Million ≈ $474.88 |
-16.28% |
| 1997-03-31 | GBX4.66 Million ≈ $567.23 |
+125.87% |
| 1996-03-31 | GBX2.06 Million ≈ $251.13 |
+6.17% |
| 1995-03-31 | GBX1.94 Million ≈ $236.53 |
-6.49% |
| 1994-03-31 | GBX2.08 Million ≈ $252.95 |
-- |
About Rua Life Sciences PLC
RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast… Read more